EFFECT OF AN ORAL CONTRACEPTIVE DRUG ON NON-ARTERIOSCLEROTIC, MALE AND FEMALE VIRGIN RATS VS. ARTERIOSCLEROTIC, MALE AND FEMALE BREEDER RATS
- Teens Do Not Gain Weight with Oral Contraceptives. Walling, Anne D. // American Family Physician;11/15/2002, Vol. 66 Issue 10, p1971
Investigates the patterns of weight change and cardiovascular risk factors in young women using oral contraceptives. Number of study participants who had been using oral contraceptives for at least six consecutive months at age 21; Body mass index of contraceptive users.
- Women's Health Risks Associated with Orthodox Medicine -- Part 3. Null, Gary; Rasio, Debora; Feldman, Martin // Townsend Letter for Doctors & Patients;Apr2002, Issue 225, p93
Identifies several problems associated with use of oral contraceptives. Prevention of pregnancy; Risks of cardiovascular diseases; Association between oral contraceptive use and cancer.
- Pill talk. Doheny, Kathleen; Caley, Nora // Shape;Jul98, Vol. 17 Issue 11, p26
Examines problems with oral contraceptives, in relation to a study conducted at the University of Michigan. Issues which can result in oral contraceptives being less effective; Importance of using a backup contraceptive when using oral contraceptives; Information on emergency contraceptive...
- Terbinafine with combined pill. // Practice Nursing;Feb2010, Vol. 21 Issue 2, p90
The article provides an answer to a question on the effect of terbinafine on the efficacy of the combined oral contraceptive pill (COCP).
- The West of Scotland coronary prevention study: Economic... Caro, J.; Klittich, W.; McGuire, A.; Ford, I.; Norrie, J.; Pettitt, D.; McMurray, J.; Shepherd, J. // BMJ: British Medical Journal (International Edition);12/13/97, Vol. 315 Issue 7122, p1577
Estimates the economic efficiency of using pravastin to prevent the transition from health to cardiovascular disease in men with hypercholesterolaemia. Subject of the study; Comparison of treatment with pravastin to one with no primary interventional; Conclusions. INSET: Key messages.
- The third generation oral contraceptive controversy. O'Brien, Paul A. // BMJ: British Medical Journal (International Edition);09/25/99, Vol. 319 Issue 7213, p795
Discusses the controversy of the third generation oral contraceptives containing desogestrel or gestodene which pose a lower risk of myocardial infarction in users. Significant findings of the third general oral contraceptives compared with the second generation; Factors behind the increasing...
- IU Launches Lipid-Lowering Program. March, Keith // Medical Update;2003, Vol. 28 Issue 8, p6
Reports on a lipid lowering program launched by the Indiana University in Indiana as of February 2003. Factors to consider in reducing the risk of cardiovascular disease; Details on lipid apheresis, a technology that offers an alternative to families with familial hypercholesterolemia; Benefits...
- Editorial. Seman, Leo // Nutrition in Clinical Care;May/Jun2000, Vol. 3 Issue 3, p127
Focuses on the benefits of nutritional interventions on cardiovascular disease and hypercholesterolemia. Health benefits of garlic; Effect of monounsaturated fats on cholesterol; Reduction of cholesterol levels with soy protein.
- Sex and Time Trends in Cardiovascular Disease Incidence and Mortality: the Framingham Heart Study, 1950â€“1989. Sytkowski, Pamela A.; D'Agostino, Ralph B.; Belanger, Albert; Kannel, William B. // American Journal of Epidemiology;1996, Vol. 143 Issue 4, p338
Variations in cardiovascular disease mortality between sexes, over time, and across regions point to population differences in the biologic, behavioral, and environmental factors influencing cardiovascular health. The authors examined 20-year trends in risk factors, incidence, and mortality...